跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,898 条关于
“Alynlam Pharmaceuticals”
全部
8,898
临床试验
525
药物
1,729
机构
2,044
资讯
4,600
去年
Huntington's Disease: Optimism Surrounds Potential Breakthroughs in 2025
去年
Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Highlights
2年前
Alnylam Anticipates Strong Growth in 2025 Driven by RNAi Therapeutics
9个月前
Alnylam Pharmaceuticals Announces $250M Manufacturing Expansion to Scale RNA Interference Therapeutics Production
去年
Alnylam Pharmaceuticals Joins Alliance for Genomic Discovery to Accelerate RNAi Drug Development
7个月前
Alnylam Pharmaceuticals Prepares for Q4 Results with Amvuttra Sales Surge and Pipeline Advances
去年
HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)
去年
Bora Pharmaceuticals Acquires Pyros Pharmaceuticals, Expanding Rare Disease Portfolio
去年
Alnylam's ALN-HTT02: First Patient Dosed in Phase 1 Huntington's Disease Trial
去年
MIRA Pharmaceuticals to Acquire SKNY Pharmaceuticals, Expanding into $200 Billion Weight Loss and Smoking Cessation Markets
第 1 页,共 460 页
上一页
下一页